ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 81 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,063,000 | -24.4% | 133,240 | -5.2% | 0.05% | -28.4% |
| Q2 2020 | $1,406,000 | +13.0% | 140,529 | -51.4% | 0.07% | +10.4% |
| Q1 2019 | $1,244,000 | -27.6% | 289,340 | -3.2% | 0.07% | -30.2% |
| Q4 2018 | $1,718,000 | -34.1% | 298,850 | +55.4% | 0.10% | -5.9% |
| Q3 2018 | $2,607,000 | +6.8% | 192,251 | -6.5% | 0.10% | +5.2% |
| Q2 2018 | $2,442,000 | -14.9% | 205,701 | -11.1% | 0.10% | -17.1% |
| Q1 2018 | $2,870,000 | +153.5% | 231,349 | +36.6% | 0.12% | +129.4% |
| Q4 2017 | $1,132,000 | -45.0% | 169,406 | -32.5% | 0.05% | -54.1% |
| Q3 2017 | $2,057,000 | +88.2% | 251,145 | +3.1% | 0.11% | +23.3% |
| Q2 2017 | $1,093,000 | -14.7% | 243,535 | +4.7% | 0.09% | -29.1% |
| Q1 2017 | $1,282,000 | +63.3% | 232,641 | +20.0% | 0.13% | +33.7% |
| Q4 2016 | $785,000 | +52.1% | 193,869 | +165.0% | 0.10% | +37.7% |
| Q3 2016 | $516,000 | -14.0% | 73,145 | -0.6% | 0.07% | -17.9% |
| Q2 2016 | $600,000 | -47.7% | 73,572 | -47.9% | 0.08% | +18.3% |
| Q1 2016 | $1,148,000 | +26.0% | 141,086 | +86.8% | 0.07% | -38.3% |
| Q4 2015 | $911,000 | – | 75,540 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |